Year None20242023202220212020201920182017201620152008 Feb 05, 2024 BioXcel Therapeutics Announces USPTO’s Allowance of Patent Application for Method of Treating Agitation in Alzheimer’s Disease Using Oromucosal Formulations of Dexmedetomidine Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Displaying 11 - 11 of 11
Feb 05, 2024 BioXcel Therapeutics Announces USPTO’s Allowance of Patent Application for Method of Treating Agitation in Alzheimer’s Disease Using Oromucosal Formulations of Dexmedetomidine